BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21389023)

  • 1. The development of quality indicators for community pharmacy care.
    De Bie J; Kijlstra NB; Daemen BJ; Bouvy ML
    BMJ Qual Saf; 2011 Aug; 20(8):666-71. PubMed ID: 21389023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Providing patient care in community pharmacies: practice and research in Finland.
    Bell JS; Väänänen M; Ovaskainen H; Närhi U; Airaksinen MS
    Ann Pharmacother; 2007 Jun; 41(6):1039-46. PubMed ID: 17504836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a framework of, and quality indicators for, general practice management in Europe.
    Engels Y; Campbell S; Dautzenberg M; van den Hombergh P; Brinkmann H; Szécsényi J; Falcoff H; Seuntjens L; Kuenzi B; Grol R;
    Fam Pract; 2005 Apr; 22(2):215-22. PubMed ID: 15722398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
    Berger K; Eickhoff C; Schulz M
    J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process indicators of quality clinical pharmacy services during transitions of care.
    ; Kirwin J; Canales AE; Bentley ML; Bungay K; Chan T; Dobson E; Holder RM; Johnson D; Lilliston A; Mohammad RA; Spinler SA
    Pharmacotherapy; 2012 Nov; 32(11):e338-47. PubMed ID: 23108762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of quality indicators for dementia diagnosis and management in a primary care setting.
    Perry M; Drasković I; van Achterberg T; van Eijken M; Lucassen P; Vernooij-Dassen M; Olde Rikkert M
    J Am Geriatr Soc; 2010 Mar; 58(3):557-63. PubMed ID: 20210818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies.
    Teichert M; Schoenmakers T; Kylstra N; Mosk B; Bouvy ML; van de Vaart F; De Smet PA; Wensing M
    Int J Clin Pharm; 2016 Aug; 38(4):870-9. PubMed ID: 27107583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting the US Institute for Safe Medication Practices' Medication Safety Self Assessment tool for community pharmacies in Finland.
    Teinilä T; Halmepuro-Jaatinen S; Yritys K; Manni K; Airaksinen M
    Int J Pharm Pract; 2012 Feb; 20(1):15-24. PubMed ID: 22236176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care in community pharmacy: practice and research in the Netherlands.
    van Mil JW
    Ann Pharmacother; 2005 Oct; 39(10):1720-5. PubMed ID: 16144881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic approach towards the development of a set of quality indicators for public reporting in community-based maternity care.
    Voerman GE; Calsbeek H; Maassen IT; Wiegers TA; Braspenning J
    Midwifery; 2013 Apr; 29(4):316-24. PubMed ID: 23357096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health services research related to performance indicators and benchmarking in Europe.
    Klazinga N; Fischer C; ten Asbroek A
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():38-47. PubMed ID: 21737528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical value of pharmacists' modifications of prescription errors.
    Buurma H; De Smet PA; Leufkens HG; Egberts AC
    Br J Clin Pharmacol; 2004 Nov; 58(5):503-11. PubMed ID: 15521898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical care in community pharmacies: practice and research in Peru.
    Alvarez-Risco A; van Mil JW
    Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring patient satisfaction with diabetes disease state management services in community pharmacy.
    Krass I; Delaney C; Glaubitz S; Kanjanarach T
    Res Social Adm Pharm; 2009 Mar; 5(1):31-9. PubMed ID: 19285287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.